Increasing TPP1, a telomere-protective protein, accelerates hair follicle stem cell activation and promotes hair regeneration in mice through both genetic and pharmacological approaches. A topical compound called TELODIN stabilizes TPP1 and demonstrates therapeutic potential for treating alopecia by reversing telomere-driven senescence in hair follicles.
Key Points
- TPP1 overexpression mobilizes dormant bulge hair follicle stem cells
- Topical TELODIN stabilizes TPP1 and promotes hair regeneration
- Telomere lengthening coordinates stem cell proliferation and migration
Longevity Analysis
This research reveals a direct mechanistic link between telomere maintenance and stem cell activation in a clinically relevant tissue. Hair follicle senescence serves as a measurable biomarker of aging; the capacity to reverse it through telomere-targeted intervention suggests similar approaches may address senescence in other regenerative tissues. The identification of TPP1 as a regulatory hub connects fundamental aging biology—telomere shortening—to practical tissue regeneration, establishing a template for interventions that coordinate telomere capping with stem cell mobilization rather than attempting broad cellular rejuvenation.
Original published by Wiley Aging Cell, by Lihui Wang, Bihan Zhao, Jiahui Yang, Ying Liang, Yitian Yao, Xiao Xiao, Long Yang, Jinghao Xia, Haoze Li, Ling Gao, Jun Zhang, Tianci Su, Hao Xu, Jiacheng Zhang, Hongyan Wang, Jun Liu, Xiaojing Hong, Jun‐Ping Liu .